参考文献/References:
[1] BRAY F,FRELAY J,SOERJOMATARM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2] PESIC M,GRETEN F R.Inflammation and cancer:tissue regeneration gone awry[J].Curr Opin Cell Biol,2016,43:55-61.
[3] GAO X,YIN J,WANG X,et al.A comprehensive comparison of hematological parameters among 39 common diseases[J].Scand J Clin Lab Invest,2019,79(4):251-259.
[4] MORI M,SHUTO K,KOSUGI C,et al.An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer[J].BMC Cancer,2018,18(1):1261.
[5] AMI M B,EDGEd S B,GREENE F L,et al.AJCC cancer staging manual[M].New York:Springer,2016:203-220.
[6] MURATA M.Inflammation and cancer[J].Environ Health Prev Med,2018,23(1):50.
[7] OCANA A,NIETO-JIMNEZ C,PANDIELLA A,et al.Neutrophils in cancer:prognostic role and therapeutic strategies[J].Mol Cancer,2017,16(1):137.
[8] LI M,DENG Q,ZHANG L,et al.The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers:a meta-analysis[J].Pathol Res Pract,2019,215(1):5-11.
[9] 胡志方,檀心广,刘燕.结直肠癌患者炎症因子相关评分对患者临床结局的预测价值分析[J].现代消化及介入诊疗,2020,25(6):749-753.
[10] 史敬东,钟志强,李有国,等.结直肠癌初治患者外周血中性粒细胞与淋巴细胞比值与临床病理特征的关系及其预后价值分析[J].癌症进展,2017,15(6):709-712.
[11] 王敏,孙亮.TK1、CEA、CA199检测在结直肠癌诊断中的应用价值[J].南京医科大学学报(自然科学版),2017,37(9):1182-1184.
[12] TENG D,WU K,SUN Y,et al.Significant increased CA199 levels in acute pancreatitis patients predicts the presence of pancreatic cancer[J].Oncotarget,2018,9(16):12745-12753.
[13] 阮万泽.不同分期结直肠癌患者血清CEA、AFP、CA199表达及临床意义[J].中国处方药,2020,18(4):149-151.
[14] 赵虹,田振华,王博扬.多肿瘤标志物联合检测的临床意义[J].中国实验诊断学,2019,23(9):1562-1563.
[15] 冯妮,李晓琳.血清癌胚抗原、糖类抗原199和肿瘤M2型丙酮酸激酶联合检测在结肠癌诊断中的价值[J].新乡医学院学报,2018,35(3):182-184.
[16] 赵宝祥,李华,张亚君,等.血清癌胚抗原、神经元特异性烯醇化酶、microRNA-20a和microRNA-210联合检测对早期小细胞肺癌的诊断价值[J].新乡医学院学报,2019,36(5):452-454.
相似文献/References:
[1]朱武凌 范秉琳.青年与老年结直肠癌C—erbB一2不同表达与DNA倍体的关系[J].新乡医学院学报,2002,19(03):170.
[2]王璧,王战会,韩保卫,等.Runt相关转录因子3在结直肠癌组织中的表达及意义[J].新乡医学院学报,2022,39(12):1127.[doi:10.7683/xxyxyxb.2022.12.005]
WANG Bi,WANG Zhanhui,HAN Baowei,et al.Expression and significance of Runt-related transcription factor 3 in colorectal cancer[J].Journal of Xinxiang Medical University,2022,39(1):1127.[doi:10.7683/xxyxyxb.2022.12.005]
[3]齐光照,李朵璐.细胞色素P450酶CYP2W1研究进展[J].新乡医学院学报,2019,36(7):698.[doi:10.7683/xxyxyxb.2019.07.025]
[4]李怡春,张 敏,杨晓煜,等.CD133在人结直肠癌组织中的表达及其与缺氧诱导因子1α和核心蛋白聚糖的相关性[J].新乡医学院学报,2019,36(11):1036.[doi:10.7683/xxyxyxb.2019.11.007]
LI Yi-chun,ZHANG Min,YANG Xiao-yu,et al.Expression of CD133 in human colorectal cancer tissues and correlation with hypoxia-induced factor-1α and decorin[J].Journal of Xinxiang Medical University,2019,36(1):1036.[doi:10.7683/xxyxyxb.2019.11.007]
[5]平贯芳,熊万成,邓智建.长链非编码RNA 浆细胞瘤转化迁移基因1在结直肠癌组织和细胞中的表达及临床意义[J].新乡医学院学报,2019,36(10):949.[doi:10.7683/xxyxyxb.2019.10.011]
PING Guan-fang,XIONG Wan-cheng,DENG Zhi-jian.Expression and clinical significance of long-chain non-coding RNA plasmacytoma variant translocation gene 1 in colorectal cancer tissues and cells[J].Journal of Xinxiang Medical University,2019,36(1):949.[doi:10.7683/xxyxyxb.2019.10.011]
[6]吕文豪,董 媛,魏子白.二甲双胍在结直肠癌治疗中的作用研究进展[J].新乡医学院学报,2021,38(7):692.[doi:10.7683/xxyxyxb.2021.07.020]
[7]姬颖华,杨晓煜,孟祥丽,等.盐酸安罗替尼联合信迪利单抗治疗标准治疗失败后微卫星稳定型结直肠癌疗效观察[J].新乡医学院学报,2021,38(8):719.[doi:10.7683/xxyxyxb.2021.08.004]
JI Yinghua,YANG Xiaoyu,MENG Xiangli,et al.Clinical efficacy of Anlotinib hydrochloride combined with Sintilimab in the treatment of microsatellite stable colorectal cancer after the failure of standard treatment[J].Journal of Xinxiang Medical University,2021,38(1):719.[doi:10.7683/xxyxyxb.2021.08.004]
[8]谢 阳,赵李红,杨昌建,等.不同肺复张策略治疗腹腔镜下结直肠癌根治术患者围手术期肺不张疗效观察[J].新乡医学院学报,2021,38(9):857.[doi:10.7683/xxyxyxb.2021.09.012]
XIE Yang,ZHAO Lihong,YANG Changjian,et al.Effect of different lung recruitment strategies in treatment of perioperative atelectasis of patients undergoing laparoscopic radical resection of colorectal cancer[J].Journal of Xinxiang Medical University,2021,38(1):857.[doi:10.7683/xxyxyxb.2021.09.012]
[9]胡德升,高 磊,王 江,等.外周血胸苷酸合成酶基因表达与中晚期结直肠癌患者FOLFOX4化学治疗敏感性和预后的相关性[J].新乡医学院学报,2020,37(10):930.[doi:10.7683/xxyxyxb.2020.10.007]
HU Desheng,GAO Lei,WANG Jiang,et al.Correlation between thymidylate synthase gene expression in peripheral blood and FOLFOX4 chemotherapy sensitivity and prognosis of patients with advanced colorectal cancer[J].Journal of Xinxiang Medical University,2020,37(1):930.[doi:10.7683/xxyxyxb.2020.10.007]
[10]王 鑫,王 钊,李元春,等.热休克蛋白70及基质金属蛋白酶-7和EHD2蛋白在结直肠癌组织中的表达及意义[J].新乡医学院学报,2019,36(5):443.[doi:10.7683/xxyxyxb.2019.05.010]
WANG Xin,WANG Zhao,LI Yuan-chun,et al.Expression and significance of heat shock protein 70,matrix metalloproteinase-7 and EHD2 in colorectal cancer tissues[J].Journal of Xinxiang Medical University,2019,36(1):443.[doi:10.7683/xxyxyxb.2019.05.010]